Interaction Between Levothyroxine and Probiotics in Hypothyroid Patients
Sponsored by Azienda USL Modena
About this trial
Last updated 8 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 9 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- primary hypothyroidism on LT4 replacement therapy
- TSH, fT3 and fT4 in the normal range
- stable LT4 dosage during the previous six months before enrolment
- Caucasian ethnicity
Exclusion Criteria
- total thyroidectomy for thyroid carcinoma
- high fiber diet
- intestinal malabsorption (e.g. bariatric surgery, inflammatory bowel diseases, coeliac disease)
- ongoing therapies interfering with LT4 absorption and/or metabolism (i.e. aluminium-containing antacids, sucralfate, proton pump inhibitors, calcium carbonate, raloxifene, bile acids sequestrants and ferrous sulfate)
- antibiotics treatment in the previous six months before enrolment